Therapeutic Asset Ratings
147 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Selnoflast
Parkinson Disease
Hoffmann-La Roche
P1
CC
(40)
Tocilizumab
Small Cell Lung Carcinoma
Hoffmann-La Roche
P1
CC
(40)
Phesgo / / 20,000 Unt In
Advanced Solid Tumors
Hoffmann-La Roche
P1/2
CC
(40)
ro7443904
Non-Hodgkin Lymphoma
Hoffmann-La Roche
P1
C
(39)
ro7515629
Ovarian Neoplasm
Hoffmann-La Roche
P1
C
(39)
ro7515629
Pancreatic Adenocarcinoma
Hoffmann-La Roche
P1
C
(39)
ro7623066
Cancer
Hoffmann-La Roche
P1
C
(39)
ro7812653
Alzheimer Disease
Hoffmann-La Roche
P1
C
(39)
Tocilizumab
Ovarian Neoplasm
Hoffmann-La Roche
P1
C
(39)
Divarasib
Colorectal Cancer
Hoffmann-La Roche
P1
C
(37)
Ocrelizumab Co-Formulated With Rhuph20
Multiple Sclerosis
Hoffmann-La Roche
P1
C
(37)
RO7121932
Multiple Sclerosis
Hoffmann-La Roche
P1
C
(37)
ro7444973
Neoplasm
Hoffmann-La Roche
P1
C
(37)
ro7515629
Renal Cell Carcinoma
Hoffmann-La Roche
P1
C
(37)
ro7673396
Neoplasm
Hoffmann-La Roche
P1
C
(37)
SY 5609
Colorectal Cancer
Hoffmann-La Roche
P1
C
(37)
Tocilizumab
Renal Cell Carcinoma
Hoffmann-La Roche
P1
C
(37)
ro7515629
Colorectal Cancer
Hoffmann-La Roche
P1
C
(36)
ro7515629
Non-Small Cell Lung Carcinoma
Hoffmann-La Roche
P1
C
(36)
Atezolizumab
Lung Cancer, Hepatocellular Carcinoma
Hoffmann-La Roche
D
(30)
203pb-dotam
Colorectal Cancer
Hoffmann-La Roche
P1
NR
(0)
212pb-dotam
Colorectal Cancer
Hoffmann-La Roche
P1
NR
(0)
Showing 126 to 147 of 147 assets
Previous
Page 6 of 6
Next
